30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert Moussa

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Derma Sciences Inc May 1, 2005 - Feb. 24, 2017
Independent Director Calmare Therapeutics Inc Jan. 23, 2012 - Oct. 15, 2015
Robert Moussa's trades of Daxor Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2006-10-31 2006-10-31
US Daxor Corp (DXR)
B Purchase
12,054 -48.3%
35.89
US$4,002,250 		12,054 -48.3% 35.89 US$4,002,250
2006-06-20 2006-06-16
US Daxor Corp (DXR)
B Purchase
49,159 +31.5%
273.40
US$4,901,405 		49,159 +31.5% 273.40 US$4,901,405